Fenofibrate for Patients With COVID-19 Requiring Hospitalization

NCT04661930 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Corona Virus Disease (COVID-19)
Respiratory Distress Syndrome
SARS-CoV-2 Infection

Interventions

DRUG: TriCor® 145mg tablets
OTHER: Placebo
OTHER: Usual care

Sponsor

Yaakov Nahmias

Collaborators

[object Object]
[object Object]
[object Object]